Microbot Medical shares are trading higher after the company announced multiple peer-reviewed abstracts have been accepted to be presented at the Annual Congress of the Cardiovascular and Interventional Radiological Society of Europe.
Portfolio Pulse from Benzinga Newsdesk
Microbot Medical announced that multiple peer-reviewed abstracts have been accepted for presentation at the Annual Congress of the Cardiovascular and Interventional Radiological Society of Europe, leading to a rise in its share prices.
June 16, 2023 | 2:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Microbot Medical shares are trading higher after the company announced multiple peer-reviewed abstracts have been accepted for presentation at a European medical congress.
The acceptance of multiple peer-reviewed abstracts for presentation at a prestigious medical congress indicates a positive development for Microbot Medical. This news is likely to increase investor confidence in the company's research and development capabilities, leading to a short-term positive impact on its stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100